A detailed history of Candriam S.C.A. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Candriam S.C.A. holds 948,266 shares of IONS stock, worth $34.6 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
948,266
Previous 948,266 -0.0%
Holding current value
$34.6 Million
Previous $45.2 Million 15.95%
% of portfolio
0.22%
Previous 0.28%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$36.45 - $47.7 $1.33 Million - $1.73 Million
36,369 Added 3.99%
948,266 $45.2 Million
Q1 2024

May 03, 2024

BUY
$42.03 - $53.55 $11.9 Million - $15.1 Million
282,830 Added 44.96%
911,897 $39.5 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $3.47 Million - $4.13 Million
80,000 Added 14.57%
629,067 $31.8 Million
Q3 2023

Nov 13, 2023

BUY
$38.5 - $47.13 $962,500 - $1.18 Million
25,000 Added 4.77%
549,067 $24.9 Million
Q2 2023

Aug 08, 2023

BUY
$34.73 - $43.33 $2.74 Million - $3.42 Million
78,870 Added 17.72%
524,067 $21.5 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $688,490 - $844,723
-20,503 Reduced 4.4%
445,197 $15.9 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $532,634 - $667,515
14,349 Added 3.18%
465,700 $17.6 Million
Q3 2022

Nov 10, 2022

SELL
$36.54 - $48.66 $4.36 Million - $5.81 Million
-119,341 Reduced 20.91%
451,351 $20 Million
Q2 2022

Aug 03, 2022

BUY
$31.71 - $43.0 $2.26 Million - $3.06 Million
71,145 Added 14.24%
570,692 $21.1 Million
Q1 2022

May 13, 2022

SELL
$29.88 - $37.04 $13.1 Million - $16.2 Million
-437,088 Reduced 46.67%
499,547 $18.5 Million
Q4 2021

Feb 10, 2022

BUY
$25.61 - $35.1 $5.39 Million - $7.38 Million
210,276 Added 28.95%
936,635 $28.5 Million
Q3 2021

Nov 09, 2021

BUY
$33.54 - $40.55 $5.83 Million - $7.05 Million
173,793 Added 31.45%
726,359 $24.4 Million
Q2 2021

Jul 20, 2021

BUY
$34.54 - $47.25 $10.6 Million - $14.4 Million
305,612 Added 123.75%
552,566 $22 Million
Q4 2020

Jan 22, 2021

SELL
$45.3 - $60.27 $305,593 - $406,581
-6,746 Reduced 2.66%
246,954 $14 Million
Q2 2020

Jul 23, 2020

SELL
$46.85 - $61.05 $374,800 - $488,400
-8,000 Reduced 3.06%
253,700 $15 Million
Q4 2019

Jan 21, 2020

SELL
$53.85 - $65.27 $1.7 Million - $2.06 Million
-31,500 Reduced 10.74%
261,700 $16,000
Q2 2019

Aug 01, 2019

SELL
$62.09 - $86.14 $6.21 Million - $8.61 Million
-100,000 Reduced 25.43%
293,200 $18.8 Million
Q1 2019

May 02, 2019

BUY
$52.92 - $81.17 $7.62 Million - $11.7 Million
144,000 Added 57.78%
393,200 $31.9 Million
Q4 2018

Feb 14, 2019

BUY
$43.37 - $59.54 $2.13 Million - $2.92 Million
49,000 Added 24.48%
249,200 $13.5 Million
Q3 2018

Nov 07, 2018

BUY
$42.88 - $53.7 $1.9 Million - $2.38 Million
44,400 Added 28.5%
200,200 $10.3 Million
Q2 2018

Aug 14, 2018

BUY
$40.53 - $50.7 $559,314 - $699,660
13,800 Added 9.72%
155,800 $6.49 Million
Q4 2017

Feb 07, 2018

SELL
$50.3 - $64.39 $50,300 - $64,390
-1,000 Reduced 0.7%
142,000 $7.14 Million
Q3 2017

Nov 03, 2017

BUY
$45.56 - $59.57 $6.52 Million - $8.52 Million
143,000
143,000 $7.25 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.